眼科

• 论著 • 上一篇    下一篇

脑红蛋白在增殖性糖尿病视网膜病变患者眼部及血清中表达的研究

李康  高晓虹 栗改云 李静 刘朝晖   

  1. 030001 太原市, 山西省眼科医院
  • 收稿日期:2016-10-17 出版日期:2017-09-25 发布日期:2017-09-28
  • 通讯作者: 高晓虹,Email:violetdaisynn@126.com
  • 基金资助:

    山西省自然科学基金(2012011039-3)

The level of neuroglobin in eye and serum of patients with proliferative diabetic retinopathy

LI Kang,  GAO Xiao-hong, LI Gai-yun, LI Jing, LIU Zhao-hui   

  1. Shanxi Eye Hospital, Taiyuan 030001, China
  • Received:2016-10-17 Online:2017-09-25 Published:2017-09-28
  • Contact: GAO Xiao-hong, Email: violetdaisynn@126.com

摘要:

目的 探讨脑红蛋白(NGB)在增殖性糖尿病视网膜病变(PDR)患者房水、玻璃体、视网膜前纤维增殖膜以及血清中的表达情况。设计 临床病例对照研究。研究对象 山西省眼科医院顺序就诊并确诊为PDR患者30例,其中Ⅳ、Ⅴ、Ⅵ期患者各10例,特发性黄斑裂孔(IMH)患者10例作为对照。方法 通过玻璃体切除手术收集患者的房水、玻璃体、视网膜前纤维增殖膜(PDR组)或内界膜(IMH组)。术前抽静脉血离心取血清。运用ELISA方法定量检测PDR各组患者及IMH患者房水、玻璃体及血清中NGB的表达量。免疫组织化学染色法观察视网膜前纤维增殖膜及内界膜中NGB的表达。各组患者房水、玻璃体、血清中NGB表达量以及视网膜前纤维增殖膜、内界膜中NGB表达阳性率的总体差异比较均采用单因素方差分析,组间多重比较采用LSD-t检验。主要指标 血清、房水、玻璃体、视网膜前纤维增殖膜(PDR组)及内界膜(IMH组)中NGB的表达量。结果 PDR各组血清、房水、玻璃体中的NGB表达均高于IMH组(F=494.433、143.923、2568.291; P均<0.001)。NGB在血清中、玻璃体中PDR4组表达量均低于PDR5组(t=-9.766、-27.578,P均<0.001),PDR4组表达量均低于PDR6组(t=-29.678、-26.419,P均<0.001),PDR5组表达量均低于PDR6组(t=-15.117,P<0.001; t=-3.231,P=0.003)。在房水中表达量,各组间两两比较均无差异(P均>0.05)。IMH组、PDR4组、PDR5组、PDR6组患者内界膜或视网膜前纤维增殖膜中NGB表达阳性率分别为0、(6.12±2.12)%、(13.43±2.05)%、(16.39±2.46)%。PDR4组低于PDR5组(t=-21.55,P<0.001);PDR4低于PDR6组(t=-25.059,P<0.001);PDR5低于PDR6组(t=-7.238,P<0.001)。结论 NGB在PDR患者血清、房水、玻璃体和视网膜前纤维增殖膜中的表达较对照组明显增加,且血清、玻璃体和视网膜前纤维增殖膜中的NGB表达量随病情加重呈递增趋势。(眼科, 2017, 26: 323-327)

关键词: 脑红蛋白, 增殖性糖尿病视网膜病变, 视网膜前增殖膜, 酶联免疫吸附试验, 免疫组织化学法

Abstract:

Objective To evaluate the expression of neuroglobin (NGB) in aqueous, vitreous, fibrous proliferation membrane and serum of patients with proliferative diabetic retinopathy (PDR). Design Clinical case control study. Participants Thirty patients who were diagnosed as PDR were divided into 3 groups equally according severity of the disease: IV, V, and VI. The control group consisted of 10 patients with idiopathic macular hole. Methods We collected aqueous, vitreous, fibrous proliferation membrane or internal limiting membrane during vitrectomy. Serum was collected before operation. The level of NGB in the aqueous, vitreous and serum was determined quantitatively using ELISA method. The expression level of NGB in the fibrous proliferation membrane or internal limiting membrane was determined using immunohistochemistry method. Main Outcome Measures The level of NGB in serum aqueous, vitreous, fibrous proliferation membrane and internal limiting membrane of patients. Results In PDR groups, the level of NGB in serum, aqueous and vitreous was significantly higher than in the idiopathic macular hole group (F=494.433, 143.923, 2568.291; all P<0.001). The  NGB level in serum and vitreous was lower in PDR4 group than in PDR5 group (t=-9.766, -27.578; both P<0.001), lower in PDR4 group than in PDR6 group(t=-29.678, -26.419; both P<0.001), lower in PDR5 group than in PDR6 group (t=-15.117, -3.231; P<0.001, P=0.003 respectively). The level of NGB in aqueous in PDR4, PDR5 and PDR6 groups was not significantly different (all P>0.05). The positive rates of NGB expression in fibrous proliferation membrane in the IMH group, PDR4 group, PDR5 group, PDR6 group were 0, (6.12±2.12)%, (13.43±2.05)%, (16.39±2.46)% respectively. The differences between any two PDR groups were statistically significant. It was lower in PDR4 group than in PDR5 group (t=-21.552, P<0.001), lower in PDR4 group than in PDR6 group(t=-25.059, P<0.001),lower in PDR5 group than in PDR6 group (t=-7.238, P<0.001). Conclusions The level of NGB in serum, aqueous, vitreous and fibrous proliferation membrane of PDR patients significantly increased compared to the control group, and increased with the severity of the disease. (Ophthalmol CHN, 2017, 26: 323-327)

Key words: neuroglobin, proliferative diabetic retinopathy, fibrous proliferation membrane, ELISA, immunohistochemistry